A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction

Cell Reports

Volumn 16, Issue 3, 2016, Pages 731-743

  Mavilio, Maria ^a   Marchetti, Valentina ^a   Fabrizi, Marta ^a,b   Stöhr, Robert ^a,c   Marino, Arianna ^a   Casagrande, Viviana ^a   Fiorentino, Loredana ^a   Cardellini, Marina ^a   Kappel, Ben ^a,c   Monteleone, Ivan ^a   Garret, Celine ^d   Mauriello, Alessandro ^a   Monteleone, Giovanni ^a   Farcomeni, Alessio ^e   Burcelin, Remy ^e   Menghini, Rossella ^a   Federici, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d University Hospital of Toulouse   (France)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BRANCHED CHAIN AMINO ACID; CCAAT ENHANCER BINDING PROTEIN ALPHA; GLUCOSE TRANSPORTER 4; GLYCOPROTEIN P 15095; INSULIN RECEPTOR; INTERLEUKIN 6 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; GLUCOSE; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DYSBIOSIS; ENERGY EXPENDITURE; FATTY LIVER; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; IMMUNOPHENOTYPING; INTESTINE FLORA; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; LIPID DIET; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; GASTROINTESTINAL TRACT; INFLAMMATION; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIVER; METABOLISM; MICROBIOLOGY; MICROFLORA; OBESITY; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; DIET, HIGH-FAT; DYSBIOSIS; FATTY LIVER; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GLUCOSE; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LIVER; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIOTA; OBESITY; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84978481301     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.06.027     Document Type: Article

References (53)

1. Anstee, Q.M., Targher, G., Day, C.P., Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10 (2013), 330–344.
2. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57 (1995), 289–300.
3. Cardellini, M., Menghini, R., Martelli, E., Casagrande, V., Marino, A., Rizza, S., Porzio, O., Mauriello, A., Solini, A., Ippoliti, A., et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58 (2009), 2396–2401.
4. Cardellini, M., Menghini, R., Luzi, A., Davato, F., Cardolini, I., D'Alfonso, R., Gentileschi, P., Rizza, S., Marini, M.A., Porzio, O., et al. Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness. Diabetes 60 (2011), 3265–3270.
5. Casagrande, V., Menghini, R., Menini, S., Marino, A., Marchetti, V., Cavalera, M., Fabrizi, M., Hribal, M.L., Pugliese, G., Gentileschi, P., et al. Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 74–81.
6. Cox, A.J., West, N.P., Cripps, A.W., Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 3 (2015), 207–215.
7. Denou, E., Lolmède, K., Garidou, L., Pomie, C., Chabo, C., Lau, T.C., Fullerton, M.D., Nigro, G., Zakaroff-Girard, A., Luche, E., et al. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. EMBO Mol. Med. 7 (2015), 259–274.
8. Duca, F.A., Sakar, Y., Lepage, P., Devime, F., Langelier, B., Doré, J., Covasa, M., Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats. Diabetes 63 (2014), 1624–1636.
9. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110 (2013), 9066–9071.
10. Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., Denis, R.G., Cochez, P., Pierard, F., Castel, J., et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat. Commun., 5, 2014, 5648.
11. Fabrizi, M., Marchetti, V., Mavilio, M., Marino, A., Casagrande, V., Cavalera, M., Moreno-Navarrete, J.M., Mezza, T., Sorice, G.P., Fiorentino, L., et al. IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity. Diabetes 63 (2014), 2086–2096.
12. Farcomeni, A., More powerful control of the false discovery rate under dependence. Stat. Methods Appl. 15 (2006), 43–73.
13. Farcomeni, A., Some results on the control of the false discovery rate under dependence. Scand. J. Stat. 34 (2007), 275–297.
14. Farcomeni, A., A review of modern multiple hypothesis testing, with particular attention to the false discovery proportion. Stat. Methods Med. Res. 17 (2008), 347–388.
15. Federici, M., Hribal, M.L., Menghini, R., Kanno, H., Marchetti, V., Porzio, O., Sunnarborg, S.W., Rizza, S., Serino, M., Cunsolo, V., et al. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J. Clin. Invest. 115 (2005), 3494–3505.
16. Ferrante, A.W. Jr., Macrophages, fat, and the emergence of immunometabolism. J. Clin. Invest. 123 (2013), 4992–4993.
17. Fiorentino, L., Vivanti, A., Cavalera, M., Marzano, V., Ronci, M., Fabrizi, M., Menini, S., Pugliese, G., Menghini, R., Khokha, R., et al. Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 51 (2010), 103–110.
18. Fiorentino, L., Cavalera, M., Mavilio, M., Conserva, F., Menghini, R., Gesualdo, L., Federici, M., Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta Diabetol. 50 (2013), 965–969.
19. Fiorentino, L., Cavalera, M., Menini, S., Marchetti, V., Mavilio, M., Fabrizi, M., Conserva, F., Casagrande, V., Menghini, R., Pontrelli, P., et al. Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. EMBO Mol. Med. 5 (2013), 441–455.
20. Johnson, A.M., Olefsky, J.M., The origins and drivers of insulin resistance. Cell 152 (2013), 673–684.
21. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., Nielsen, J., Bäckhed, F., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
22. Kellermayer, R., Dowd, S.E., Harris, R.A., Balasa, A., Schaible, T.D., Wolcott, R.D., Tatevian, N., Szigeti, R., Li, Z., Versalovic, J., Smith, C.W., Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J. 25 (2011), 1449–1460.
23. Khan, M.T., Nieuwdorp, M., Bäckhed, F., Microbial modulation of insulin sensitivity. Cell Metab. 20 (2014), 753–760.
24. Khatri, P., Sirota, M., Butte, A.J., Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput. Biol., 8, 2012, e1002375.
25. Kim, K.A., Gu, W., Lee, I.A., Joh, E.H., Kim, D.H., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE, 7, 2012, e47713.
26. Koppe, L., Pillon, N.J., Vella, R.E., Croze, M.L., Pelletier, C.C., Chambert, S., Massy, Z., Glorieux, G., Vanholder, R., Dugenet, Y., et al. p-Cresyl sulfate promotes insulin resistance associated with CKD. J. Am. Soc. Nephrol. 24 (2013), 88–99.
27. Kraakman, M.J., Kammoun, H.L., Allen, T.L., Deswaerte, V., Henstridge, D.C., Estevez, E., Matthews, V.B., Neill, B., White, D.A., Murphy, A.J., et al. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance. Cell Metab. 21 (2015), 403–416.
28. Laferrère, B., Reilly, D., Arias, S., Swerdlow, N., Gorroochurn, P., Bawa, B., Bose, M., Teixeira, J., Stevens, R.D., Wenner, B.R., et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci. Transl. Med., 3, 2011, 80re2.
29. Li, P., Lu, M., Nguyen, M.T., Bae, E.J., Chapman, J., Feng, D., Hawkins, M., Pessin, J.E., Sears, D.D., Nguyen, A.K., et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 285 (2010), 15333–15345.
30. Lustgarten, M.S., Price, L.L., Chalé, A., Fielding, R.A., Metabolites related to gut bacterial metabolism, peroxisome proliferator-activated receptor-alpha activation, and insulin sensitivity are associated with physical function in functionally-limited older adults. Aging Cell 13 (2014), 918–925.
31. Lynch, C.J., Adams, S.H., Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 10 (2014), 723–736.
32. Marino, A., Menghini, R., Fabrizi, M., Casagrande, V., Mavilio, M., Stoehr, R., Candi, E., Mauriello, A., Moreno-Navarrete, J.M., Gómez-Serrano, M., et al. ITCH deficiency protects from diet-induced obesity. Diabetes 63 (2014), 550–561.
33. McNelis, J.C., Olefsky, J.M., Macrophages, immunity, and metabolic disease. Immunity 41 (2014), 36–48.
34. Mehal, W.Z., The Gordian Knot of dysbiosis, obesity and NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10 (2013), 637–644.
35. Menghini, R., Menini, S., Amoruso, R., Fiorentino, L., Casagrande, V., Marzano, V., Tornei, F., Bertucci, P., Iacobini, C., Serino, M., et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 136 (2009), 663–672.e4.
36. Menghini, R., Casagrande, V., Menini, S., Marino, A., Marzano, V., Hribal, M.L., Gentileschi, P., Lauro, D., Schillaci, O., Pugliese, G., et al. TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. Diabetes 61 (2012), 454–462.
37. Mohammed, F.F., Smookler, D.S., Taylor, S.E., Fingleton, B., Kassiri, Z., Sanchez, O.H., English, J.L., Matrisian, L.M., Au, B., Yeh, W.C., Khokha, R., Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat. Genet. 36 (2004), 969–977.
38. Monteleone, I., Federici, M., Sarra, M., Franzè, E., Casagrande, V., Zorzi, F., Cavalera, M., Rizzo, A., Lauro, R., Pallone, F., et al. Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine. Gastroenterology 143 (2012), 1277–1287.e1, 4.
39. Moschen, A.R., Kaser, S., Tilg, H., Non-alcoholic steatohepatitis: a microbiota-driven disease. Trends Endocrinol. Metab. 24 (2013), 537–545.
40. Murphy, G., Murthy, A., Khokha, R., Clipping, shedding and RIPping keep immunity on cue. Trends Immunol. 29 (2008), 75–82.
41. Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F., Haqq, A.M., Shah, S.H., Arlotto, M., Slentz, C.A., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9 (2009), 311–326.
42. Patsouris, D., Li, P.P., Thapar, D., Chapman, J., Olefsky, J.M., Neels, J.G., Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 8 (2008), 301–309.
43. Qureshi, R., Sacan, A., Weighted set enrichment of gene expression data. BMC Syst. Biol., 7(Suppl 4), 2013, S10.
44. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
45. Scheller, J., Garbers, C., Rose-John, S., Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities. Semin. Immunol. 26 (2014), 2–12.
46. Schumacher, N., Meyer, D., Mauermann, A., von der Heyde, J., Wolf, J., Schwarz, J., Knittler, K., Murphy, G., Michalek, M., Garbers, C., et al. Shedding of endogenous interleukin-6 receptor (IL-6R) is governed by a disintegrin and metalloproteinase (ADAM) proteases while a full-length IL-6R isoform localizes to circulating microvesicles. J. Biol. Chem. 290 (2015), 26059–26071.
47. Serino, M., Menghini, R., Fiorentino, L., Amoruso, R., Mauriello, A., Lauro, D., Sbraccia, P., Hribal, M.L., Lauro, R., Federici, M., Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes 56 (2007), 2541–2546.
48. Tilg, H., Kaser, A., Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121 (2011), 2126–2132.
49. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
50. Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., Sitaraman, S.V., Knight, R., Ley, R.E., Gewirtz, A.T., Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
51. Wentworth, J.M., Naselli, G., Brown, W.A., Doyle, L., Phipson, B., Smyth, G.K., Wabitsch, M., O'Brien, P.E., Harrison, L.C., Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59 (2010), 1648–1656.
52. Wu, H., Perrard, X.D., Wang, Q., Perrard, J.L., Polsani, V.R., Jones, P.H., Smith, C.W., Ballantyne, C.M., CD11c expression in adipose tissue and blood and its role in diet-induced obesity. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 186–192.
53. Yan, I., Schwarz, J., Lucke, K., Schumacher, N., Schumacher, V., Schmidt, S., Rabe, B., Saftig, P., Donners, M., Rose-John, S., et al. ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Ralpha from the cell surface of leukocytes during inflammatory responses. J. Leukoc. Biol. 99 (2016), 749–760.